September 2005

Tramadol painkiller in Europe

Labopharm Inc. received regulatory approval for its once-daily pain killer, Tramadol, in 22 European countries and will launch the product by the end of the year.

Labopharm has previously secured licensing and distribution agreements for once-daily tramadol with Aventis France for France, Gruppo Angelini for Italy, and Esteve SA for Spain and Portugal.

Labopharm now only needs marketing authorization from the individual countries, which include Germany, Italy, Spain and Portugal. It expects to start gaining that in the next month and into the first half of 2006.

The product has been approved in a daily dose range from 100 mg to 400 mg.

"Our strategy is to launch our product as quickly as possible following........" said Labopharm's chief executive.

Back to Tramadol News

 






 
Home  |   About Tramadol   |   About Ultram   |   Bookmark US   |  Health Resources   |   Contact  |   SiteMap
TramadolHome.Com © 2005 All rights reserved  
All trademarks and registered trademarks are of their respective companies. Ultram® is a registered trademark of Ortho-McNeil Pharmaceutical, Inc.
Tramadol is the generic form of Ultram
Information provided on www.TramadolHome.com is for informational purposes only and is not a substitute for professional medical advice. Only your healthcare provider should diagnose your healthcare problems and prescribe treatment.